PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (OTCBB: BJCT), a leading developer of needle-free injection therapy systems, today announced that Bioject’s needle-free injection ...

Needle-free drug injection company PharmaJet is close to completing a $5 million fundraising round of financing that would fund the production of 5 million syringes to deliver the polio vaccine.

The Tropis ® intradermal (ID) Needle-free Injection System overcomes the challenges of traditional Mantoux injection and can easily be integrated into commercial products and development projects.

SWIFTWATER, Pa., Sept. 19, 2011 /PRNewswire via COMTEX/ -- Sanofi Pasteur, the vaccines division of Sanofi , announced today that it began shipping the new Fluzone® Intradermal (Influenza Virus ...

PharmaJet® and EVA Pharma Sign Distribution Agreement of Needle-free Polio Injection for Egypt · GlobeNewswire Inc. The introduction of Tropis into immunization programs supports Egypt’s “1000 Golden ...

PharmaJet presentation will highlight the results of recent immunization studies using needle-free intradermal (ID) delivery for polio immunization campaigns. Data reinforces how increased coverage, ...

WASHINGTON – Kids aren’t the only needle-phobes. A lot of adults don’t get the shots they need, including the flu vaccine, because they fear the pain. But now there is a new kind of “ouchless” flu ...

PharmaJet will deliver two presentations on October 27 focusing on current and future applications of their needle-free technology. The Tropis ® intradermal (ID) Needle-free Injection System overcomes ...